NCT00274937 2022-10-25
Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
Children's Oncology Group
Phase 3 Completed
Clinical Trials
6 trialsNCT00217438 2015-08-21
Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma
Fred Hutchinson Cancer Center
Phase 3 Completed
NCT00003313 2014-11-21
Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
Radiation Therapy Oncology Group
Phase 3 Completed
NCT00058071 2013-07-09
Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer
GOG Foundation
Phase 3 Completed
NCT00003994 2013-06-14
Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer
Children's Oncology Group
Phase 3 Completed
NCT00158691 2005-09-12
Intravenous Versus Subcutaneous Amifostine in Prevention of Xerostomia After RT for Head and Neck Carcinomas
Groupe Oncologie Radiotherapie Tete et Cou
Phase 3 Completed